Literature DB >> 21475016

Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy.

Ryota Matsuo1, Yoritaka Nakano, Nobuhiro Ohkohchi.   

Abstract

OBJECTIVE: This study examines the applicability of platelet infusion therapy for liver regeneration in vivo.
BACKGROUND: We recently reported that platelets accumulate in the liver immediately after extended hepatectomy and promote residual liver regeneration. Liver regeneration depends on the number of accumulated platelets in the sinusoids.
METHODS: Male Sprague-Dawley rats underwent 70% hepatectomy and were then assigned to groups that were infused with 1 mL of either platelet-rich plasma (PRP; 1 × 10(9) platelets/mL) in normal saline (NS) or NS via the portal vein. We then analyzed liver regeneration and the signaling pathways that are related to liver regeneration and function. The dynamics of platelets infused via the portal vein were visualized before and after hepatectomy.
RESULTS: The liver/body weight ratio after 70% hepatectomy was significantly higher and the Ki-67 labeling index was higher in the PRP, than in the NS group. The Akt pathway was activated earlier in the PRP, than in the NS group with concurrent ERK1/2 pathway activation, but this was prolonged in the PRP group. Many more platelets infused via the portal vein accumulated in the sinusoid after 70% hepatectomy, and serum liver function tests and histological findings revealed that portal infusion did not cause liver damage.
CONCLUSIONS: Platelets infused via the portal vein promoted liver regeneration after 70% hepatectomy in rats without liver damage. These findings indicate that PRP administration could be a useful part of liver regeneration therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21475016     DOI: 10.1097/SLA.0b013e318211caf8

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  35 in total

Review 1.  The role of microvesicles in tissue repair.

Authors:  Ciro Tetta; Stefania Bruno; Valentina Fonsato; Maria Chiara Deregibus; Giovanni Camussi
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

Review 2.  Novel therapy for liver regeneration by increasing the number of platelets.

Authors:  Kazuhiro Takahashi; Soichiro Murata; Nobuhiro Ohkohchi
Journal:  Surg Today       Date:  2012-11-21       Impact factor: 2.549

3.  Prominent effect of platelet on improvement of liver cirrhosis.

Authors:  Hui Xu; Xiao-Meng Jiang; Ying Wu; Yu-Mei Li; Yun-Wen Zheng; Nobuhiro Ohkohchi
Journal:  AME Case Rep       Date:  2020-04-30

Review 4.  Hemostasis and Liver Regeneration.

Authors:  Patrick Starlinger; James P Luyendyk; Dafna J Groeneveld
Journal:  Semin Thromb Hemost       Date:  2020-09-09       Impact factor: 4.180

Review 5.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

Review 6.  Update on the Mechanisms of Liver Regeneration.

Authors:  Morgan E Preziosi; Satdarshan P Monga
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

7.  Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Authors:  Kerstin Abshagen; Franziska Mertens; Christian Eipel; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

8.  Human platelets inhibit liver fibrosis in severe combined immunodeficiency mice.

Authors:  Kazuhiro Takahashi; Soichiro Murata; Kiyoshi Fukunaga; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

Review 9.  Platelets as Modulators of Liver Diseases.

Authors:  Ton Lisman; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2017-09-12       Impact factor: 4.180

10.  Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy.

Authors:  Hai-Qing Wang; Jian Yang; Jia-Yin Yang; Wen-Tao Wang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.